Shiny Nair, PhD
Research Scientist
Research & Publications
Biography
News
Coauthors
Selected Publications
- Severe pulmonary arterial hypertension in Gaucher disease type 1Basiri M, Ruan J, Nair S, Guo L, Mistry P. Severe pulmonary arterial hypertension in Gaucher disease type 1. Molecular Genetics And Metabolism 2023, 138: 107021. DOI: 10.1016/j.ymgme.2022.107021.
- The risk of hepatocellular carcinoma is markedly increased in Gaucher diseaseBasiri M, Ruan J, Nair S, Lau H, Mistry P, Taddei T. The risk of hepatocellular carcinoma is markedly increased in Gaucher disease. Molecular Genetics And Metabolism 2023, 138: 107022. DOI: 10.1016/j.ymgme.2022.107022.
- Single cell resolution of neurodegeneration in Gaucher diseaseNair S, Belinsky G, Ruan J, Basiri M, Klinger K, Mistry P. Single cell resolution of neurodegeneration in Gaucher disease. Molecular Genetics And Metabolism 2023, 138: 107233. DOI: 10.1016/j.ymgme.2022.107233.
- Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapyBoddupalli CS, Nair S, Belinsky G, Gans J, Teeple E, Nguyen TH, Mehta S, Guo L, Kramer ML, Ruan J, Wang H, Davison M, Kumar D, Vidyadhara D, Zhang B, Klinger K, Mistry PK. Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy. ELife 2022, 11: e79830. PMID: 35972072, PMCID: PMC9381039, DOI: 10.7554/elife.79830.
- The clinical spectrum of SARS-CoV-2 infection in Gaucher disease: Effect of both a pandemic and a rare disease that disrupts the immune systemNarayanan P, Nair S, Balwani M, Malinis M, Mistry P. The clinical spectrum of SARS-CoV-2 infection in Gaucher disease: Effect of both a pandemic and a rare disease that disrupts the immune system. Molecular Genetics And Metabolism 2021, 135: 115-121. PMID: 34412940, PMCID: PMC8361210, DOI: 10.1016/j.ymgme.2021.08.004.
- Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathyNair S, Bar N, Xu ML, Dhodapkar M, Mistry PK. Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy. Molecular Genetics And Metabolism 2020, 129: 286-291. PMID: 32044242, PMCID: PMC8223251, DOI: 10.1016/j.ymgme.2020.01.009.
- Delineating the role of myeloid cells and brain microglia in Gaucher diseaseBoddupalli V, Nair S, Belinsky G, Mehta S, Mistry P. Delineating the role of myeloid cells and brain microglia in Gaucher disease. Molecular Genetics And Metabolism 2020, 129: s31. DOI: 10.1016/j.ymgme.2019.11.054.
- Antigen-mediated regulation in monoclonal gammopathies and myelomaNair S, Sng J, Boddupalli CS, Seckinger A, Chesi M, Fulciniti M, Zhang L, Rauniyar N, Lopez M, Neparidze N, Parker T, Munshi NC, Sexton R, Barlogie B, Orlowski R, Bergsagel L, Hose D, Flavell RA, Mistry PK, Meffre E, Dhodapkar MV. Antigen-mediated regulation in monoclonal gammopathies and myeloma. JCI Insight 2018, 3: e98259. PMID: 29669929, PMCID: PMC5931125, DOI: 10.1172/jci.insight.98259.
- Natural Killer T Cells in Cancer ImmunotherapyNair S, Dhodapkar MV. Natural Killer T Cells in Cancer Immunotherapy. Frontiers In Immunology 2017, 8: 1178. PMID: 29018445, PMCID: PMC5614937, DOI: 10.3389/fimmu.2017.01178.
- Association of lysolipids with Gaucher disease - associated and sporadic gammopathiesNair S, Sng J, Zhang L, Branagan A, Liu J, Boddupalli C, Meffre E, Mistry P, Dhodapkar M. Association of lysolipids with Gaucher disease - associated and sporadic gammopathies. Molecular Genetics And Metabolism 2017, 120: s100. DOI: 10.1016/j.ymgme.2016.11.251.
- ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cellsBoddupalli CS, Nair S, Gray SM, Nowyhed HN, Verma R, Gibson JA, Abraham C, Narayan D, Vasquez J, Hedrick CC, Flavell RA, Dhodapkar KM, Kaech SM, Dhodapkar MV. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. Journal Of Clinical Investigation 2016, 126: 3905-3916. PMID: 27617863, PMCID: PMC5096804, DOI: 10.1172/jci85329.
- Clonal Immunoglobulin against Lysolipids in the Origin of MyelomaNair S, Branagan AR, Liu J, Boddupalli CS, Mistry PK, Dhodapkar MV. Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma. New England Journal Of Medicine 2016, 374: 555-561. PMID: 26863356, PMCID: PMC4804194, DOI: 10.1056/nejmoa1508808.
- Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammationNair S, Boddupalli CS, Verma R, Liu J, Yang R, Pastores GM, Mistry PK, Dhodapkar MV. Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation. Blood 2014, 125: 1256-1271. PMID: 25499455, PMCID: PMC4335081, DOI: 10.1182/blood-2014-09-600270.
- Type II NKT-TFH Cells Against Gaucher Lipids Regulate B Cell Immunity and InflammationNair S, Boddupalli C, Verma R, Liu J, Ruhua Y, Pastores G, Mistry P, Dhodapkar M. Type II NKT-TFH Cells Against Gaucher Lipids Regulate B Cell Immunity and Inflammation. Blood 2014, 124: 755. DOI: 10.1182/blood.v124.21.755.755.
- Endocytosis of Mycobacterium tuberculosis Heat Shock Protein 60 Is Required to Induce Interleukin-10 Production in Macrophages*Parveen N, Varman R, Nair S, Das G, Ghosh S, Mukhopadhyay S. Endocytosis of Mycobacterium tuberculosis Heat Shock Protein 60 Is Required to Induce Interleukin-10 Production in Macrophages*. Journal Of Biological Chemistry 2013, 288: 24956-24971. PMID: 23846686, PMCID: PMC3750191, DOI: 10.1074/jbc.m113.461004.
- Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myelomaRichter J, Neparidze N, Zhang L, Nair S, Monesmith T, Sundaram R, Miesowicz F, Dhodapkar KM, Dhodapkar MV. Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma. Blood 2012, 121: 423-430. PMID: 23100308, PMCID: PMC3548165, DOI: 10.1182/blood-2012-06-435503.
- Pathogenesis in tuberculosis: transcriptomic approaches to unraveling virulence mechanisms and finding new drug targetsMukhopadhyay S, Nair S, Ghosh S. Pathogenesis in tuberculosis: transcriptomic approaches to unraveling virulence mechanisms and finding new drug targets. FEMS Microbiology Reviews 2012, 36: 463-485. PMID: 22092372, DOI: 10.1111/j.1574-6976.2011.00302.x.
- The PPE18 Protein of Mycobacterium tuberculosis Inhibits NF-κB/rel–Mediated Proinflammatory Cytokine Production by Upregulating and Phosphorylating Suppressor of Cytokine Signaling 3 ProteinNair S, Pandey AD, Mukhopadhyay S. The PPE18 Protein of Mycobacterium tuberculosis Inhibits NF-κB/rel–Mediated Proinflammatory Cytokine Production by Upregulating and Phosphorylating Suppressor of Cytokine Signaling 3 Protein. The Journal Of Immunology 2011, 186: 5413-5424. PMID: 21451109, DOI: 10.4049/jimmunol.1000773.
- Glutathione-Redox Balance Regulates c-rel–Driven IL-12 Production in Macrophages: Possible Implications in Antituberculosis ImmunotherapyAlam K, Ghousunnissa, Nair S, Valluri VL, Mukhopadhyay S. Glutathione-Redox Balance Regulates c-rel–Driven IL-12 Production in Macrophages: Possible Implications in Antituberculosis Immunotherapy. The Journal Of Immunology 2010, 184: 2918-2929. PMID: 20164428, DOI: 10.4049/jimmunol.0900439.
- The PPE18 of Mycobacterium tuberculosis Interacts with TLR2 and Activates IL-10 Induction in MacrophageNair S, Ramaswamy PA, Ghosh S, Joshi DC, Pathak N, Siddiqui I, Sharma P, Hasnain SE, Mande SC, Mukhopadhyay S. The PPE18 of Mycobacterium tuberculosis Interacts with TLR2 and Activates IL-10 Induction in Macrophage. The Journal Of Immunology 2009, 183: 6269-6281. PMID: 19880448, DOI: 10.4049/jimmunol.0901367.
- The PPE Protein Rv1196 of Mycobacterium tuberculosis Exploits the TLR2 Signaling in Macrophages Eliciting an Anti-Inflammatory Response by Producing IL-10Mukhopadhyay S, Nair S, Mande S, Hasnain S. The PPE Protein Rv1196 of Mycobacterium tuberculosis Exploits the TLR2 Signaling in Macrophages Eliciting an Anti-Inflammatory Response by Producing IL-10. International Journal Of Infectious Diseases 2008, 12: e477. DOI: 10.1016/j.ijid.2008.05.1351.
- Association of Strong Immune Responses to PPE Protein Rv1168c with Active Tuberculosis â–¿Khan N, Alam K, Nair S, Valluri VL, Murthy KJ, Mukhopadhyay S. Association of Strong Immune Responses to PPE Protein Rv1168c with Active Tuberculosis â–¿. MSphere 2008, 15: 974-980. PMID: 18400969, PMCID: PMC2446626, DOI: 10.1128/cvi.00485-07.
- Nitric Oxide: Friendly Rivalry in TuberculosisMukhopadhyay S, Nair S, Hasnain S. Nitric Oxide: Friendly Rivalry in Tuberculosis. Current Signal Transduction Therapy 2007, 2: 121-128. DOI: 10.2174/157436207780619536.
- Nitric oxide inhibits interleukin-12 p40 through p38 MAPK-mediated regulation of calmodulin and c-relBoddupalli CS, Ghosh S, Rahim S, Nair S, Ehtesham NZ, Hasnain SE, Mukhopadhyay S. Nitric oxide inhibits interleukin-12 p40 through p38 MAPK-mediated regulation of calmodulin and c-rel. Free Radical Biology And Medicine 2006, 42: 686-697. PMID: 17291992, DOI: 10.1016/j.freeradbiomed.2006.12.014.